$IMNM target buy back zone...Now that I exited yesterday, setting a watch price to reconsider some calls or commons. If we pull back maybe the 10 day sma touch could be between $19-$20 range to start entering back in...by UnknownUnicorn39241543
$IMNM out for now...Did the start of what I wanted, got 100% on my October calls, not liquid enough to risk it so I closed out. Still could be alot to go though...by UnknownUnicorn39241540
$IMNM got the first move...Now to see how much we have left, I have over a month to option expiration so I am still going to wait and see if we can hit $30, but a quick move to $25 and I'm out...by UnknownUnicorn39241542
$IMNM just getting started?....Finally pulled the trigger, probably too late. Got some $25 calls for Oct, only option chain that had a bit of volume. Commons probably make more sense however. We'll see if we can catch a bigger move here...by UnknownUnicorn39241541
$IMNM on watch...Liking the chart and the news on this one...positive results from anti-body cocktails, one of those stocks that could run huge if we do see continued COVID issues. by UnknownUnicorn3924154220
$IMNM is gonna fall todayPupm&Dump trading strategy idea. $IMNM is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $23,08; stop-loss — $24,37; take-profit — $20,52. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me! Shortby KozakHlib2
$IMNM Discovers Antibodies Capable of Neutralizing SARS-CoV-2Immunome Discovers Antibodies Capable of Neutralizing Multiple SARS-CoV-2 Variants, Including the South African Variant, in Pseudovirus Testing finance.yahoo.comby AlenCiken1